Westover Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Buy |
14,579
+841
| +6% | +$90.3K | 0.31% | 69 |
|
|
2025
Q1 | $1.39M | Sell |
13,738
-934
| -6% | -$94.2K | 0.31% | 73 |
|
|
2024
Q4 | $1.31M | Sell |
14,672
-399
| -3% | -$35.6K | 0.29% | 82 |
|
|
2024
Q3 | $1.26M | Sell |
15,071
-825
| -5% | -$69.1K | 0.24% | 88 |
|
|
2024
Q2 | $1.22M | Sell |
15,896
-1,156
| -7% | -$89K | 0.32% | 82 |
|
|
2024
Q1 | $1.17M | Buy |
17,052
+1,620
| +10% | +$111K | 0.34% | 74 |
|
|
2023
Q4 | $892K | Sell |
15,432
-231
| -1% | -$13.4K | 0.29% | 82 |
|
|
2023
Q3 | $827K | Sell |
15,663
-475
| -3% | -$25.1K | 0.3% | 77 |
|
|
2023
Q2 | $873K | Sell |
16,138
-1,120
| -6% | -$60.6K | 0.3% | 79 |
|
|
2023
Q1 | $863K | Sell |
17,258
-1,300
| -7% | -$65K | 0.32% | 74 |
|
|
2022
Q4 | $859K | Sell |
18,558
-100
| -0.5% | -$4.63K | 0.34% | 73 |
|
|
2022
Q3 | $723K | Buy |
18,658
+666
| +4% | +$25.8K | 0.28% | 81 |
|
|
2022
Q2 | $671K | Sell |
17,992
-10
| -0.1% | -$373 | 0.25% | 82 |
|
|
2022
Q1 | $797K | Buy |
18,002
+10,925
| +154% | +$484K | 0.25% | 84 |
|
|
2021
Q4 | $301K | Buy |
7,077
+1,370
| +24% | +$58.3K | 0.09% | 149 |
|
|
2021
Q3 | $248K | Buy |
5,707
+819
| +17% | +$35.6K | 0.08% | 155 |
|
|
2021
Q2 | $209K | Buy |
+4,888
| New | +$209K | 0.07% | 176 |
|
|
2020
Q2 | – | Sell |
-8,988
| Closed | -$293K | – | 112 |
|
|
2020
Q1 | $293K | Sell |
8,988
-801
| -8% | -$26.1K | 0.16% | 91 |
|
|
2019
Q4 | $443K | Sell |
9,789
-340
| -3% | -$15.4K | 0.2% | 93 |
|
|
2019
Q3 | $412K | Sell |
10,129
-220
| -2% | -$8.95K | 0.19% | 92 |
|
|
2019
Q2 | $445K | Sell |
10,349
-353
| -3% | -$15.2K | 0.22% | 83 |
|
|
2019
Q1 | $411K | Sell |
10,702
-50
| -0.5% | -$1.92K | 0.21% | 81 |
|
|
2018
Q4 | $380K | Buy |
+10,752
| New | +$380K | 0.24% | 77 |
|